Literature DB >> 8227445

Effect of embolisation of meningioma on Ki-67 proliferation index.

W Paulus1, J Meixensberger, E Hofmann, W Roggendorf.   

Abstract

The proliferation indices (PIs) were determined in 33 meningiomas using two monoclonal antibodies to the Ki-67 antigen (Ki-67 and MIB1). PIs obtained using Ki-67 on frozen material were intermediate between the lowest and highest MIB1 PIs determined in paraffin wax sections. Preoperative embolisation did not influence Ki67 PI, but four of the 15 embolised tumours showed substantially increased MIB1 PIs around embolisation necroses. Proliferation can be reliably assessed in routinely processed meningioma tissues using MIB1; and increased perinecrotic PIs may occur in embolised meningiomas without being an indication of malignancy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227445      PMCID: PMC501532          DOI: 10.1136/jcp.46.9.876

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues.

Authors:  J Gerdes; M H Becker; G Key; G Cattoretti
Journal:  J Pathol       Date:  1992-09       Impact factor: 7.996

2.  Proliferating cell nuclear antigen expression in central nervous system neoplasms.

Authors:  A Allegranza; S Girlando; G L Arrigoni; S Veronese; F A Mauri; M Gambacorta; B Pollo; P Dalla Palma; M Barbareschi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 3.  Morphological markers in neuro-oncology.

Authors:  P Kleihues; M Kiessling; R C Janzer
Journal:  Curr Top Pathol       Date:  1987

4.  Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67.

Authors:  W Roggendorf; T Schuster; J Peiffer
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

5.  Localization of basic fibroblast growth factor, a mitogen and angiogenic factor, in human brain tumors.

Authors:  W Paulus; C Grothe; M Sensenbrenner; T Janet; I Baur; M Graf; W Roggendorf
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Preoperative embolization of intracranial meningiomas.

Authors:  H P Richter; W Schachenmayr
Journal:  Neurosurgery       Date:  1983-09       Impact factor: 4.654

7.  Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.

Authors:  G Cattoretti; M H Becker; G Key; M Duchrow; C Schlüter; J Galle; J Gerdes
Journal:  J Pathol       Date:  1992-12       Impact factor: 7.996

8.  Influence of preoperative dexamethasone therapy on proliferating cell nuclear antigen (PCNA) expression in comparison to other parameters in meningiomas.

Authors:  J Gottschalk; S Goebel; G Jautzke; H Martin; C Zimmer; S Märzheuser-Brands; J Cervós-Navarro
Journal:  Histol Histopathol       Date:  1992-10       Impact factor: 2.303

  8 in total
  5 in total

1.  Expression of p53, MDM2 protein and Ki-67 antigen in recurrent meningiomas.

Authors:  M Ohkoudo; H Sawa; M Hara; K Saruta; T Aiso; R Ohki; H Yamamoto; E Maemura; Y Shiina; M Fujii; I Saito
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

2.  Increased proliferative activity due to necroses induced by pre-operative embolization in benign meningiomas.

Authors:  E Patsouris; R Laas; C Hagel; D Stavrou
Journal:  J Neurooncol       Date:  1998-12       Impact factor: 4.130

3.  Preoperative embolization of intracranial meningiomas: efficacy, technical considerations, and complications.

Authors:  D M S Raper; R M Starke; F Henderson; D Ding; S Simon; A J Evans; J A Jane; K C Liu
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-10       Impact factor: 3.825

4.  Embolized meningiomas: risk of overgrading and neo-angiogenesis.

Authors:  Valeria Barresi; Giovanni Branca; Francesca Granata; Concetta Alafaci; Maria Caffo; Giovanni Tuccari
Journal:  J Neurooncol       Date:  2013-03-18       Impact factor: 4.130

Review 5.  Pathology and molecular genetics of meningioma: recent advances.

Authors:  Makoto Shibuya
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-12-20       Impact factor: 1.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.